This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Wayne State University. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Joyce Reyes: Innovator in HER2 Antigenic Polypeptide Compositions
Introduction
Joyce Reyes is a prominent inventor based in Rochester Hills, MI (US). She has made significant contributions to the field of immunotherapy, particularly in the development of HER2 antigenic polypeptide compositions. Her work focuses on innovative methods for treating and preventing carcinomas, showcasing her dedication to advancing medical science.
Latest Patents
Joyce Reyes holds a patent for HER2 antigenic polypeptide compositions and methods for their use in the treatment and prevention of carcinomas. This patent includes antigenic polypeptides of the growth factor receptor HER2, designed to break the tolerance of a host against self HER2. The compositions feature HER2 polypeptides with specific amino acid substitutions, enhancing their effectiveness. Additionally, her patent outlines gene expression constructs, vaccine compositions, and immunization methods that utilize these substituted HER2 polypeptides.
Career Highlights
Joyce Reyes is affiliated with Wayne State University, where she continues her research and development in the field of immunotherapy. Her innovative approach has led to advancements in understanding how to immunize mammalian subjects against self HER2, which is crucial for effective cancer treatment.
Collaborations
Joyce collaborates with esteemed colleagues, including Richard Donovan Jones and Wei-Zen Wei. These partnerships enhance her research efforts and contribute to the broader scientific community's understanding of HER2-related therapies.
Conclusion
Joyce Reyes is a trailblazer in the field of immunotherapy, with her patent on HER2 antigenic polypeptide compositions representing a significant advancement in cancer treatment. Her work at Wayne State University and collaborations with fellow researchers underscore her commitment to innovation in medical science.